Order results by:
| Issue | Title | |
| Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
| M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
| Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
| Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities | Abstract similar documents |
| R. E. Kalinin, I. A. Suchkov, M. M. Uporov, D. S. Titov, M. Yu. Klishchenko | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
| M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
| Vol 16, No 4 (2023) | Socio-economic burden of respiratory syncytial viral infection of the lower respiratory tract in children aged from birth to 5 years in the Russian Federation: modeling results | Abstract similar documents |
| V. I. Ignatyeva, D. Yu. Ovsyannikov, A. E. Tsygankov, E. E. Yagnenkova, V. R. Amirova, M. M. Maryanyan, A. S. Mokrova | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
| Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
| Vol 16, No 4 (2023) | Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis | Abstract similar documents |
| A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva | ||
| Vol 16, No 2 (2023) | Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin | ||
| "... developed in the scientific school of Academician of the Russian Academy of Sciences Yu.I. Zhuravlev ..." | ||
| Vol 16, No 3 (2023) | Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia | Abstract similar documents |
| N. A. Avxentyev, Yu. V. Makarova | ||
| Vol 16, No 4 (2023) | Comparative chemomicrobiomic analysis of bacteriocins | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... . pneumoniae, P. aeruginosa, S. aureus, S. epidermidis, S. pneumoniae), skin diseases (M. audouinii, T ..." | ||
| Vol 16, No 2 (2023) | Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice | Abstract similar documents |
| M. S. Soboleva | ||
| Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| Vol 16, No 1 (2023) | Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin | ||
| Vol 16, No 2 (2023) | Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination | Abstract similar documents |
| I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
| Vol 16, No 3 (2023) | Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer | Abstract similar documents |
| I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova | ||
| Vol 16, No 3 (2023) | The prospects for the use of vitamin B12 derivatives in pharmacology | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. A. Maiorova | ||
| Vol 16, No 3 (2023) | Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov | ||
| "... Yu.I. Zhuravlev were used. Results. CoQ10 is involved in the regulation of inflammation and exhibits ..." | ||
| Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract similar documents |
| D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| Vol 16, No 4 (2023) | Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova | ||
| Vol 16, No 4 (2023) | Legal particularities of AI technology usage in real-world data formation | Abstract similar documents |
| V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya | ||
| Vol 16, No 1 (2023) | Modern biomarkers of acute kidney injury | Abstract similar documents |
| D. I. Korabelnikov, M. O. Magomedaliev | ||
| Vol 16, No 1 (2023) | Prospects for using high-throughput sequencing methods to identify new biomarkers of response and resistance to antitumor therapy | Abstract similar documents |
| M. А. Sorokina, T. R. Grishina | ||
| Vol 16, No 1 (2023) | Principles of medical care standards development based on clinical guidelines | Abstract similar documents |
| Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy | ||
| Vol 16, No 2 (2023) | Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance | Abstract similar documents |
| N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova | ||
| Vol 16, No 4 (2023) | Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer | Abstract similar documents |
| E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko | ||
| Vol 16, No 2 (2023) | New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma | Abstract similar documents |
| M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina | ||
| Vol 16, No 1 (2023) | Clinical approbation today: analysis of current problems and solutions | Abstract similar documents |
| V. V. Omelyanovskiy, D. V. Lukyantseva, T. I. Alekseeva, Yu. V. Voropaeva, T. A. Tomilina, R. A. Teryan, A. O. Gadzhieva | ||
| Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
| I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
| Vol 16, No 2 (2023) | Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko | ||
| Vol 16, No 2 (2023) | Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow | Abstract similar documents |
| E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova | ||
| Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract similar documents |
| O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
| Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
| A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
| Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract similar documents |
| I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
| Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| Vol 16, No 1 (2023) | Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 | Abstract similar documents |
| D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin | ||
| Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
| V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
| Vol 16, No 4 (2023) | Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation | Abstract similar documents |
| M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova | ||
| 1 - 44 of 44 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
